Figure 1
Figure 1. Cumulative incidence rates of t-AML/MDS grouped by the amount of BEACOPP chemotherapy received. Pts, patients.

Cumulative incidence rates of t-AML/MDS grouped by the amount of BEACOPP chemotherapy received. Pts, patients.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal